UK:
The Issue Of Liquidity Mismatch Will Be Under The Investor And Regulatory Spotlight In 2020
11 December 2019
Clyde & Co
To print this article, all you need is to be registered or login on Mondaq.com.
Following the FCA's introduction of new rules for funds
investing in inherently illiquid assets, and the tussle between the
EU and UK regulatory authority over whose regulatory regime was to
blame for 2019's "liquidity crisis", fund managers
and platform providers can expect additional regulatory scrutiny
over the effectiveness of their liquidity management.
IFAs who do not consider liquidity issues when advising on
suitability are also exposed to potential claims and regulatory
attention. As investors wake up to the potential for liquidity
risks, claims professionals will be alive to the potential for
"contagion risk" and underwriters will also be assessing
what questions they need to ask fund managers and IFAs regarding
their management of liquidity risk.
Read the rest of our insurance predictions here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Finance and Banking from UK
Asset Recovery Comparative Guide
Bird & Bird
Asset Recovery Comparative Guide for the jurisdiction of UK, check out our comparative guides section to compare across multiple countries
FCA's Consultation Paper
Cadwalader, Wickersham & Taft LLP
Since 3 January 2018, firms that provide portfolio management or investment advice on an independent basis must pay for the research they obtain...
Regulation Round Up
Proskauer Rose LLP
Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation.
FCA To Permit Research Bundling
Akin Gump Strauss Hauer & Feld LLP
The Financial Conduct Authority (FCA) is seeking views on proposed rules that would allow asset managers to opt for bundled payments for third-party investment research, reversing a significant aspect of the UK's implementation of research rules under the Markets in Financial Instruments Directive (MiFID II).